SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 5.76 |
| Enterprise Value ($M) | 11.68 |
| Book Value ($M) | -4.14 |
| Book Value / Share | -0.16 |
| Price / Book | -1.39 |
| NCAV ($M) | -10.20 |
| NCAV / Share | -0.40 |
| Price / NCAV | -0.56 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -5.45 |
| Return on Assets (ROA) | -1.26 |
| Return on Equity (ROE) | -6.52 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.19 |
| Current Ratio | 0.24 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.39 |
| Assets | 8.45 |
| Liabilities | 12.59 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | KfW | 4.40 | -99.93 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,834,458 | 4,789,098 | 38.30 | |
| 1,438,590 | 3,903,385 | 36.85 | |
| 1,626,552 | 4,126,256 | 39.42 | |
| 1,494,576 | 3,385,179 | 44.15 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MRKR – Marker Therapeutics, Inc. | MTEM – Molecular Templates, Inc. |
| MTEX – Mannatech, Incorporated | NATR – Nature's Sunshine Products, Inc. |
| NERV – Minerva Neurosciences, Inc. |
Financial data and stock pages provided by
Fintel.io